These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16155677)
1. Proliferating cell nuclear antigen index and nm23 expression in osteosarcoma in relation to disease- free survival and tumor grade. Unal VS; Ayhan A; Tokgozoglu MA Saudi Med J; 2005 Sep; 26(9):1475-7. PubMed ID: 16155677 [No Abstract] [Full Text] [Related]
2. [Protein expression of Skp2 in osteosarcoma and its relation with prognosis]. Liao QD; Zhong D; Chen Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):606-11. PubMed ID: 18667774 [TBL] [Abstract][Full Text] [Related]
3. Ezrin expression predicts survival in stage IIB osteosarcomas. Kim MS; Song WS; Cho WH; Lee SY; Jeon DG Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma]. Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294 [TBL] [Abstract][Full Text] [Related]
7. The expression of CRM1 is associated with prognosis in human osteosarcoma. Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467 [TBL] [Abstract][Full Text] [Related]
8. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
9. Expression of survivin and correlation with PCNA in osteosarcoma. Wang W; Luo H; Wang A J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146 [TBL] [Abstract][Full Text] [Related]
11. Preliminary observation on the correlation between nm23 expression and Ki-67 antigen with early metastasis of human osteosarcoma. Liao W; Chiu KY; Han S; Li F; Qiu J; Chow SP Chin Med J (Engl); 1998 Sep; 111(9):813-7. PubMed ID: 11155673 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002 [TBL] [Abstract][Full Text] [Related]
13. Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior. Okada K; Hasegawa T; Yokoyama R Hum Pathol; 2001 Jul; 32(7):726-33. PubMed ID: 11486171 [TBL] [Abstract][Full Text] [Related]
14. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity. Korabiowska M; Hönig JF; Jawien J; Knapik J; Stachura J; Cordon-Cardo C; Fischer G In Vivo; 2005; 19(6):1093-6. PubMed ID: 16277028 [TBL] [Abstract][Full Text] [Related]
15. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325 [TBL] [Abstract][Full Text] [Related]
16. Growth patterns of osteosarcoma predict patient survival. Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966 [TBL] [Abstract][Full Text] [Related]
17. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer. Demirbaş S; Sücüllü I; Yildirim S; Celenk T Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis. Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923 [TBL] [Abstract][Full Text] [Related]
20. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]